National AI Strategy Committee and Health Ministry Join Bio Data Donation to Expand Medical and Bio AI Use
TECHWORLD ·
✦ AI Summary
The National AI Strategy Committee and the Ministry of Health and Welfare took part in a direct donation drive to build national bio data.
The National Integrated Bio Big Data Project will run from 2024 to 2032, with a target scale of bio big data for 1 million people.
The government plans to expand eligibility for participation and begin the first data release in November.
event for donating bio data for the National Integrated Bio Big Data Project, held at Severance Hospital in Sinchon, Seoul.
The event was attended by about 40 people, including Ha Jung-woo, standing vice chair of the National AI Strategy Committee; more than 20 committee members; Health and Welfare Minister Jeong Eun-kyeong; Koh Sang-baek, head of the Korea Health Industry Development Institute; and Severance Hospital officials. The attendees donated their personal bio data.
The National Integrated Bio Big Data Project is based on the voluntary participation of the public. The project targets the collection of health information, genetic information, specimens and more.
The project is a national research infrastructure initiative to be used for precision medicine and the development of new drugs and medical devices. The project period runs from 2024 to 2032, and the target scale is the construction of bio big data for 1 million people.
The government has set 2028 as the first-stage target and plans to recruit 772,000 participants in that stage, but as of last September, participation stood at about 220,000 people, leading the National AI Strategy Committee to conclude that broader participation is needed. In response, the committee proposed the donation event.
The government has expanded the eligibility for participation in the project. Previously, participation was centered on people eligible for the national health screening program for the general public, but under the revised rules, even people who are not eligible for health screenings can participate if they want to join the research. Non-eligible participants will take part after going through testing procedures at designated recruitment institutions.
The scope of specimens collected includes blood and urine, and the specimens will be preserved at the National Biobank of Korea at the Korea Disease Control and Prevention Agency. Genomic, clinical and public data will be integrated and built at the Korea Health Information Service databank, and researchers will be able to use the relevant human resources and data after review.
The government plans to use the data for disease prevention, the development of diagnostic and treatment methods, precision medicine, and research on new drugs and medical devices. Minister Jeong said that starting with the first data release in November, the scope of research use will be expanded.
Ha Jung-woo, standing vice chair of the National AI Strategy Committee, said that a key source of strength in winning the upper hand in the global competition for medical and bio AI innovation is trustworthy, high-quality bio data. He added that he hopes the donation event will help broaden public participation and take precision medicine and drug development capabilities to the next level.
Minister Jeong said the National Integrated Bio Big Data is a public asset completed through the individual participation of citizens. She said the ministry will support the safe and broad use of the data, starting with the first release in November, so that the results of medical innovation can be returned to the public.
Source: TECHWORLD · Kim Seung-gi
Original: https://www.epnc.co.kr/news/articleView.html?idxno=408259
References
This article was produced with the help of an automated content generation algorithm.
Source: TECHWORLD
View originalThis article was summarized and organized by BizCrush based on the original article from TECHWORLD. For exact quotations and full details, please refer to the original article.